$305.06-0.3%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 6, 2026
Just reported
From UFP Technologies, Inc.'s results release of November 3, 2026; its quarterly report has since been filed.
Actual
$172.4M
+12% y/y
-0.9% q/q
Guided
—
No guide given
Actual
$2.64
+25% y/y
-1.5% q/q
Guided
—
No guide given
EPS, adjusted: $2.64
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $172.4M | $154.6M | +11.57% |
| Profit | $20.6M | $16.4M | +25.84% |
| Profit per share | $2.64 | $2.11 | +25.12% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
UFP Technologies, Inc. reported on November 3, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
“Our third quarter and year-to-date results reflect continued solid execution across the UFP platform and progress toward our long-term growth strategy,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
UFP Technologies is a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products. The company’s single-use and single-patient devices and components are used across a wide range of medical products in segments including robotic assisted surgery, patient beds and handling, infection control, cardiovascular, orthopedics and spine and wound care.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from UFP Technologies, Inc.’s Item 2.02 8-K filed November 3, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Actual
$27.6M
+18% y/y
-1.8% q/q
Guided
—
No guide given
Operating income, adjusted: $30.1M
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.